Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 90

Similar articles for PubMed (Select 20730044)

1.
2.

Therapeutic epilepsy research: from pharmacological rationale to focal adenosine augmentation.

Boison D, Stewart KA.

Biochem Pharmacol. 2009 Dec 15;78(12):1428-37. doi: 10.1016/j.bcp.2009.08.005. Epub 2009 Aug 12. Review.

3.

Adenosine dysfunction in epilepsy.

Boison D.

Glia. 2012 Aug;60(8):1234-43. doi: 10.1002/glia.22285. Epub 2011 Dec 22. Review.

4.

Adenosine dysfunction in astrogliosis: cause for seizure generation?

Li T, Quan Lan J, Fredholm BB, Simon RP, Boison D.

Neuron Glia Biol. 2007 Nov;3(4):353-66. doi: 10.1017/S1740925X0800015X.

5.

The adenosine kinase hypothesis of epileptogenesis.

Boison D.

Prog Neurobiol. 2008 Mar;84(3):249-62. doi: 10.1016/j.pneurobio.2007.12.002. Epub 2007 Dec 23. Review.

6.

Adenosine Augmentation Therapy.

Boison D.

In: Noebels JL, Avoli M, Rogawski MA, Olsen RW, Delgado-Escueta AV, editors. Jasper's Basic Mechanisms of the Epilepsies [Internet]. 4th edition. Bethesda (MD): National Center for Biotechnology Information (US); 2012.

7.

Adenosine kinase is a target for the prediction and prevention of epileptogenesis in mice.

Li T, Ren G, Lusardi T, Wilz A, Lan JQ, Iwasato T, Itohara S, Simon RP, Boison D.

J Clin Invest. 2008 Feb;118(2):571-82. doi: 10.1172/JCI33737.

8.

Adenosine kinase as a target for therapeutic antisense strategies in epilepsy.

Theofilas P, Brar S, Stewart KA, Shen HY, Sandau US, Poulsen D, Boison D.

Epilepsia. 2011 Mar;52(3):589-601. doi: 10.1111/j.1528-1167.2010.02947.x. Epub 2011 Jan 28.

9.

Adenosine augmentation therapies (AATs) for epilepsy: prospect of cell and gene therapies.

Boison D.

Epilepsy Res. 2009 Aug;85(2-3):131-41. doi: 10.1016/j.eplepsyres.2009.03.019. Epub 2009 May 9. Review.

10.

Uncoupling of astrogliosis from epileptogenesis in adenosine kinase (ADK) transgenic mice.

Li T, Lan JQ, Boison D.

Neuron Glia Biol. 2008 May;4(2):91-9. doi: 10.1017/S1740925X09990135. Epub 2009 Aug 13.

11.

Astrogliosis in epilepsy leads to overexpression of adenosine kinase, resulting in seizure aggravation.

Fedele DE, Gouder N, Güttinger M, Gabernet L, Scheurer L, Rülicke T, Crestani F, Boison D.

Brain. 2005 Oct;128(Pt 10):2383-95. Epub 2005 Jun 1.

12.

Adenosine kinase, epilepsy and stroke: mechanisms and therapies.

Boison D.

Trends Pharmacol Sci. 2006 Dec;27(12):652-8. Epub 2006 Oct 23. Review.

PMID:
17056128
13.

Comorbidities in Neurology: Is adenosine the common link?

Boison D, Aronica E.

Neuropharmacology. 2015 May 13;97:18-34. doi: 10.1016/j.neuropharm.2015.04.031. [Epub ahead of print] Review.

PMID:
25979489
14.

Overexpression of adenosine kinase in cortical astrocytes and focal neocortical epilepsy in mice.

Shen HY, Sun H, Hanthorn MM, Zhi Z, Lan JQ, Poulsen DJ, Wang RK, Boison D.

J Neurosurg. 2014 Mar;120(3):628-38. doi: 10.3171/2013.10.JNS13918. Epub 2013 Nov 22.

15.

Adenosine kinase is a new therapeutic target to prevent ischemic neuronal death.

Boison D, Shen HY.

Open Drug Discov J. 2010 Jan 1;2(3):108-118.

16.

Role of adenosine in status epilepticus: a potential new target?

Boison D.

Epilepsia. 2013 Sep;54 Suppl 6:20-2. doi: 10.1111/epi.12268. Review.

17.

Engineered adenosine-releasing cells for epilepsy therapy: human mesenchymal stem cells and human embryonic stem cells.

Boison D.

Neurotherapeutics. 2009 Apr;6(2):278-83. doi: 10.1016/j.nurt.2008.12.001. Review.

18.

Inhibitory RNA in epilepsy: research tools and therapeutic perspectives.

Boison D.

Epilepsia. 2010 Sep;51(9):1659-68. doi: 10.1111/j.1528-1167.2010.02672.x. Epub 2010 Jul 15. Review.

19.

Adenosine kinase: exploitation for therapeutic gain.

Boison D.

Pharmacol Rev. 2013 Apr 16;65(3):906-43. doi: 10.1124/pr.112.006361. Print 2013 Jul. Review.

20.

Adenosine-based cell therapy approaches for pharmacoresistant epilepsies.

Boison D.

Neurodegener Dis. 2007;4(1):28-33. Review.

PMID:
17429216
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk